The sell-side on Wall Steet is predicting BioTelemetry, Inc. (NASDAQ:BEAT) to grow at an accelerated rate over the next five years. Sell-side analysts are looking for the company to grow 30.51% over the next year and 21.90% over the next five years.
BioTelemetry, Inc. (NASDAQ:BEAT)’s trailing 12- months EPS is 1.55. Last year, their EPS growth was 586.40% and their EPS growth over the past five years was 21.90%.
Let’s start off by taking a look at how the stock has been performing recently. Over the past twelve months, BioTelemetry, Inc. (NASDAQ:BEAT)’s stock was 31.77%. Last week, it was -2.32%, 8.27% over the last quarter, and 40.91% for the past half-year.
Over the past 50 days, BioTelemetry, Inc. stock was -12.72% off of the high and 11.98% removed from the low. Their 52-Week High and Low are noted here. -12.72% (High), 101.60%, (Low).
BioTelemetry, Inc. (NASDAQ:BEAT)’s performance this year to date is 31.77%. The stock has performed -2.32% over the last seven days, 7.29% over the last thirty, and 8.27% over the last three months. Over the last six months, BioTelemetry, Inc.’s stock has been 40.91% and 92.61% for the year.
FUTURE GROWTH ESTIMATES AND RECOMMENDATIONS
Wall Street analysts are have a consensus analyst recommendation of 1.50 on the stock. This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Brokerages covering the name have a $38.00 on the stock.
The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. Where quoted, past performance is not indicative of future performance.